StoneX Group’s Milestone Scientific MLSS Stock Holding History

StoneX Group’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,000	Closed	-$7.2K	–	605
2022 Q4	$7.2K	Hold	15,000	–	–	﹤0.01%	474
2022 Q3	$11.8K	Buy	+15,000	New	+$14.6K	﹤0.01%	297

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFS

Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

StoneX Group's MLSS Position: Q1 2023 in Review

StoneX Group sold out of Milestone Scientific (MLSS) in Q1 2023, closing a stake of 15,000 shares — an estimated $7.2K sold.

StoneX Group first reported a position in MLSS in Q3 2022 and held it in 2 quarters. The position peaked at $11.8K in Q3 2022. 28 funds tracked by Wall St. Rank hold MLSS as of Q1 2023.

StoneX Group reported no remaining Milestone Scientific position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 15,000 Milestone Scientific shares in Q1 2023, an estimated $7.2K.
StoneX Group first reported a position in Milestone Scientific in Q3 2022 and held it in 2 quarters.
StoneX Group's Milestone Scientific position peaked at $11.8K in Q3 2022.
28 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.